The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

总之，普纳替尼的临床应用是肿瘤治疗史上“向死而生”的典范。其以突破性疗效拯救无数濒危患者的同时，也迫使医学界重新审视“风险-获益”的伦理边界。未来，随着分子分型的精细化与毒性管理手段的革新，普纳替尼或将褪去“最后选择”的悲情色彩，进化为兼顾安全与疗效的治愈利器。在这条充满挑战的征途上，科学与人文的交织，终将照亮白血病治疗的终极愿景。 返回搜狐，查看更多 ...

Self-hosted AI Starter Kit is an open-source Docker Compose template designed to swiftly initialize a comprehensive local AI and low-code development environment ...

Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.

March 25, 2025 • What would you do if you had more hours in a day? Here's how to carve out time for your interests and passions — even when you have a lot of responsibilities.

Podcasts Self-Improvement Life Kit From NPR Everyone needs a little help being a human. From sleep to saving money to parenting and more, host Marielle Segarra talks to experts to get the best ...

According to Telix Pharmaceuticals, the product has a longer shelf-life (up to 6 hours) and an extended distribution radius compared with other gallium-based products.

Investing.com — 周四，摩根大通开始对亚盛医药集团（NASDAQ:AAPG）进行覆盖，给予"增持"股票评级，并设定27.00美元的目标价。该公司目前市值为16亿美元，股价为每股18.37美元。亚盛医药是一家总部位于中国的商业化阶段生物技术公司，因其在全球市场的进展而受到认可，其产品组合包括已获批准和处于后期阶段的针对各种癌症的产品。根据 InvestingPro ...

达沙替尼以 Sprycel 等品牌出售，是一种靶向治疗药物，用于治疗某些慢性粒细胞白血病（CML）和急性淋巴细胞白血病（ALL）。具体来说，它用于治疗费城染色体阳性（Ph+）的病例。该药为口服药。 达沙替尼 20mg、50mg、70mg、80mg、100mg、140mg；片剂。 【药理类别 ...

Imatinib, a drug that targets the BCR-ABL tyrosine kinase, has proved remarkably effective in restoring normal blood formation in people with CML; nevertheless, most individuals in remission have ...

Everything about the U-2 is unique. The U-2 was designed for a very specific mission, and the designer of the U-2, Kelly Johnson, once said, and I paraphrase, “If you want this aircraft to go high, I ...